H.C. Wainwright has reduced its price target for Vivani Medical (VIVN) from $4 to $3.50, reflecting a minor adjustment in analyst expectations for the small-cap medical device company.
- H.C. Wainwright lowers Vivani Medical's price target to $3.50 from $4
- The adjustment reflects a minor shift in analyst expectations
- Vivani Medical operates in the healthcare sector
- The change is unlikely to influence broader market trends
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.